10 years on burned patients with AKI started on RRT and found that early RRT approach reduced mortality of burned patients with AKI. Early RRT could halt the accumulation of toxic wastes that interfere healing of burned wounds and affect hemodynamic stability of patients. RRT also allows better management of fluid, electrolytes and acid-base balance. All these advantages could improve overall outcome of burned patients with AKI. Fluid overload is the single most important predictor of mortality in such patients and Continuous Renal Replacement Therapy (CRRT) is the preferred modality to manage it, alongwith AKI and metabolic disturbances. In India, ECMO with CRRT is a rarely used modality and very few centers practice it. Objective: To assess the experience of a tertiary care center in India of combining ECMO with CRRT during the first 3 years of inception. Method: We collected data retrospectively of 30 patients on ECMO from Dec 2013 to Dec 2016 at our center. All data related to prevalence of AKI (by AKIN criteria), indications, modality and access for RRT and associated complications were collected. Outcome parameters like survival and net fluid balance were determined. Results: Of the 30 cases, 18 (60%) underwent some form of RRT while on ECMO. Nine patients (50%) each were on VenoArterial (VA) and VenoVenous (VV) ECMO. Seven (38.9%) of these were on RRT pre ECMO also. The commonest indication was AKI (88.8%, 16/ 18), associated with metabolic acidosis(AKI+Met acidosis 66.7% (12/ 18). Fluid overload was the second commonest indication(27.8% (5/ 18). Independent access was commoner (12 cases; 66.7%) than access via ECMO circuit for RRT 10(55.6%) cases. A CRRT device was used in 7 and an inline hemofilter was used in 3 cases. In 4 cases, ECMO circuit access was switched to independent access due to complications: 2 had damaged CRRT filter due to high pressure gradients; one had recurrent clotting in CRRT circuit and one had ECMO pump failure due to microbubbles in the circuit. One of the 5 overloaded (20%) and one of 13 non overloaded patients survived (7.7%). Of 12 patients with met acidosis on RRT, acidosis was corrected in 8(66.7%): (of which 7 were weaned off ECMO; 2 survived). Mortality rates were high on patients with CRRT and ECMO (16 of 18 cases, 88.9%) as compared to those without RRT (2 of 12; 16.7%). The survivors on ECMO had a much less positive fluid balance than non survivors. Conclusions: The incidence of AKI was high (16/30 , 53.3%) in our study and a majority required RRT. The associated mortality was higher in these patients. Our study shows that CRRT is a safe technique for maintenance of fluid and acid base balance. Independent access for CRRT was found to be safer in our patients. Patients with less positive fluid balance had a better survival. (CRRT). There was evidence that ECMO patient requiring CRRT had higher mortality due to increased severity of illness, but it is uncertain how CRRT affects outcomes of ECMO patients. Objectives: To explore the characteristics of ECMO survivors who underwent concomitant CRRT. Methodology: Retrospective chart review of 27 adult ECMO patients with CRRT in a university-affiliated hospital in 2015 -2016. Results: 12 patients had veno-venous ECMO and 15 had veno-arterial ECMO. Indications for ECMO were hypoxemic respiratory failure refractory to conventional therapy, cardiogenic shock associated with myocardial infarction, myocarditis and cardiac arrest. Mean age was 49.4AE14.8 years. 9 ECMO-CRRT patients survived and 18 died. There were more patients with primary respiratory diseases in survivor group (77.8% vs 17.8%, p¼0.01). Similar findings were observed between survivors and non-survivors for ECMO blood flow rate (3.96AE0.56 vs 3.5AE0.6, p¼0.06), ECMO duration (16.7AE14.1 vs 13.8AE16.1, p¼0.64) and length of stay in intensive care unit (ICU) (29.3AE25.6 vs 15.0AE17.0, p¼0.16). CRRT-ECMO configuration was the same for all cases, except for one case in which CRRT was conducted with non-tunneled dialysis catheter. Indications for CRRT treatment included acute kidney injury, fluid overload and metabolic disturbance. 23 patients received systemic ECMO anticoagulation with unfractionated heparin infusion at 12-18unit/kg/hour while 4 patients in non-survivor group received regional citrate anticoagulation for CRRT. Baseline creatinine before CRRT was 327.7AE233.9umol/L and percentage creatinine change was 41.4AE21.2%. CRRT treatment hours (151.6AE191.1 hours), total fluid removal with CRRT (12.9AE18.1 liters) and number of hemofilter change (5.0AE4.6) were not associated to increase in mortality. Conclusion: In this series of 27 patients managed with ECMO and concomitant CRRT in an adult ICU, survival to ICU discharge was 33.3%. Mortality risk was increased in patients with circulatory failure but not it was not associated with CRRT treatment modality.
higher in these patients. Our study shows that CRRT is a safe technique for maintenance of fluid and acid base balance. Independent access for CRRT was found to be safer in our patients. Patients with less positive fluid balance had a better survival. Indications for ECMO were hypoxemic respiratory failure refractory to conventional therapy, cardiogenic shock associated with myocardial infarction, myocarditis and cardiac arrest. Mean age was 49.4AE14.8 years. 9 ECMO-CRRT patients survived and 18 died. There were more patients with primary respiratory diseases in survivor group (77.8% vs 17.8%, p¼0.01). Similar findings were observed between survivors and non-survivors for ECMO blood flow rate (3.96AE0.56 vs 3.5AE0.6, p¼0.06), ECMO duration (16.7AE14.1 vs 13.8AE16.1, p¼0.64) and length of stay in intensive care unit (ICU) (29.3AE25.6 vs 15.0AE17.0, p¼0.16). CRRT-ECMO configuration was the same for all cases, except for one case in which CRRT was conducted with non-tunneled dialysis catheter. Indications for CRRT treatment included acute kidney injury, fluid overload and metabolic disturbance. 23 patients received systemic ECMO anticoagulation with unfractionated heparin infusion at 12-18unit/kg/hour while 4 patients in non-survivor group received regional citrate anticoagulation for CRRT. Baseline creatinine before CRRT was 327.7AE233.9umol/L and percentage creatinine change was 41.4AE21.2%. CRRT treatment hours (151.6AE191.1 hours), total fluid removal with CRRT (12.9AE18.1 liters) and number of hemofilter change (5.0AE4.6) were not associated to increase in mortality. Conclusion: In this series of 27 patients managed with ECMO and concomitant CRRT in an adult ICU, survival to ICU discharge was 33.3%. Mortality risk was increased in patients with circulatory failure but not it was not associated with CRRT treatment modality. Objective: This study aimed to describe the pharmacokinetics (PK) of vancomycin in Malaysian critically ill patients receiving CRRT, and the achievement of its therapeutic target, the ratio of the AUC to the minimum inhibitory concentration (MIC) of causative pathogen (AUC/ MIC >400), using a standard dosing regimen (750 mg 12 hourly). Methodology: This was a prospective PK study of vancomycin using standard dosing regimen, in critically ill patients receiving continuous venovenous haemofiltration (CVVH). Blood samples were collected at ten sampling times during a dosing interval. PK analyses were evaluated using non-compartmental method. Vancomycin trough concentrations (15-20 mg/L), and the achievement of the ratio of AUC/ MIC>400, based on selected susceptibility breakpoint (MIC¼1 mg/L), were evaluated. Obtaining trough concentration between 15-20 mg/L relatively achieved the desired AUC/MIC >400 for vancomycin during CVVH. Higher trough concentration (e.g 20-25 mg/L) may be required when targeting for a higher MIC (e.g >1mg/L). Initiation of a higher dosing regimen could also be necessary, particularly in patients undergoing CVVH with significant residual native renal function. Further data is required, from continuation of this study, to clarify the findings.
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